Anti-biofilm Wound Dressing Market (2026 - 2033)

Anti-biofilm Wound Dressing Market Summary

The global anti-biofilm wound dressing market size was valued at USD 848.1 million in 2025 and is projected to grow from USD 1,013.6 million in 2026 to USD 2,000.0 million by 2033, at a CAGR of 9.6% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 43.5% in 2025. The increasing incidence of chronic diseases such as diabetes, cancer, and other autoimmune diseases is anticipated to increase the incidence rate of chronic and acute wounds across the globe. Factors such as antimicrobial resistance, unhealthy & sedentary lifestyles, and tobacco & alcohol consumption are contributing to the rising prevalence of non-communicable diseases. They are among the key factors driving market growth.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Market Dynamics

Analyst Perspective

The anti-biofilm wound dressing market is growing in importance as healthcare providers seek more effective ways to treat chronic and hard-to-heal wounds. Demand is expected to favor products that can improve healing outcomes and help reduce the risk of infection. Companies with strong clinical evidence, trusted healthcare relationships, and specialized wound care expertise are likely to strengthen their market position. Over time, treatment effectiveness and patient outcomes will play a larger role in purchasing decisions than product cost alone.

Mode of Mechanism Insights

The chemical mode of mechanism segment held the largest market share of over 40.0% in 2025 and is anticipated to witness significant growth over the forecast period, owing to the rising prevalence of chronic wounds and the increasing number of surgeries worldwide. Chemical-based antibiofilm wound-dressing products provide multifaceted action against biofilms, thereby increasing the healing rate and recovery efficiency of chronic wounds. It also reduces the biofilm burden on both chronic & acute wounds and lowers the risk of acquiring recontamination with microorganisms. The chemical segment is further fragmented into ionic silver, iodine, EDTA, and others.

The chemical mode of the mechanism segment is anticipated to witness the fastest CAGR over the forecast period. The presence of several players offering anti-biofilm wound-dressing products containing iodine and ionic silver is the major factor driving segment growth. In addition, researchers are taking the initiative to introduce advanced anti-biofilm wound dressings to the market to improve the treatment of chronic and acute wounds. For instance, in May 2024, the European Union awarded approximately USD 1.72 million to the InnovAntiBiofilm project to develop novel antibiotic adjuvants targeting biofilm-associated infections. Such funding initiatives are accelerating innovation in biofilm management and treatment technologies, thereby driving market growth during the forecast period.

Application Insights

The chronic wounds segment accounted for the largest revenue share, approximately 60.0%, in 2025, owing to the increasing prevalence of chronic diseases, particularly diabetes, worldwide. Chronic or non-healing wounds occur when there is no significant healing of an injury for about 4 weeks. These types of wounds progress and heal more slowly than expected or do not heal at all. Symptoms of chronic wounds include increased infection and increased pain. This can be due to pressure on or around the wound, exposure to bacteria or trauma, or insufficient blood & oxygen supply. It is estimated that 1%-2% of the population will develop a chronic wound at some point in their lifetime.

According to recent clinical evidence published by the National Library of Medicine (StatPearls, updated 2025), diabetic foot ulcers alone affect approximately 6.3% of the global diabetic population, with a lifetime risk of 19-34%. In the U.S., prevalence among Medicare patients with diabetes is estimated at around 8%. At the same time, chronic wounds such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers continue to contribute significantly to healthcare burden and amputation risk. Rising diabetes prevalence, aging populations, and associated complications are expected to increase the incidence of chronic wounds further, thereby driving demand for advanced wound care solutions.

The acute wounds segment is anticipated to witness the fastest growth over the forecast period, driven by rising cases of burns & trauma and the increasing number of surgeries worldwide. An acute wound is an injury to the skin that occurs unexpectedly and includes incisions, abrasions, burns, scratches, and puncture wounds. It heals at a normal rate, following the regular wound-healing process. These types of wounds can occur anywhere on the body and range from small scratches to deep wounds. The acute wounds segment is further classified into surgical or traumatic wounds and burn wounds. Treating acute wounds depends on their severity and location. However, the primary treatment includes wound dressing and biofilm prevention. Thus, the increasing number of patients with acute wounds is expected to boost market growth.

End Use Insights

The hospital segment dominated the market for wound care, accounting for the largest revenue share of around 45.0% in 2025, driven by the upsurge in surgical procedures and the increasing number of sports-related injuries, burns, and trauma cases that require the use of wound care products to prevent surgical site infections. For instance, according to the Centers for Disease Control and Prevention (CDC), emergency departments in the U.S. recorded approximately 43.5 million injury-related visits in 2022, while total injury-related deaths reached over 271,000 in 2024. The segment is anticipated to grow during the forecast period.

The home healthcare segment is expected to witness the fastest CAGR during the forecast period. During the pandemic, home healthcare wound care products were in greater demand. These services offer several advantages to patients, including personal care and home-delivered meals. This is expected to be a major driver of the market. According to the U.S. Bureau of Labor Statistics, employment of home health and personal care aides in the U.S. is projected to increase from approximately 4.35 million workers in 2024 to 5.09 million workers by 2034, representing a 17% growth rate and the addition of nearly 740,000 new jobs. The rising demand for home-based care services, driven by an aging population and the shift toward community-based healthcare, is expected to support market growth during the forecast period.

Regional Insights

North America dominated the anti-biofilm wound dressing industry in 2025 and is expected to witness a considerable CAGR over the forecast period. The increasing incidence of sports injuries, the rising number of road accidents, and the presence of several key players in the region are expected to drive market growth. In addition, the presence of a highly developed healthcare infrastructure and favorable reimbursement policies is expected to drive market growth over the forecast period.

Asia Pacific Anti-Biofilm Wound Dressing Market Trends

The Asia Pacific anti-biofilm wound dressing market is anticipated to grow the fastest during the forecast period. The presence of developing countries such as China, India, and Japan is anticipated to boost market growth in the Asia Pacific region. In addition, the rapidly aging population in this region, along with an increasing number of obese and diabetic patients, the use of anti-biofilm wound dressing products in this region is anticipated to increase. Moreover, medical tourism in this region has contributed to increased demand for anti-biofilm wound-dressing products. The rising geriatric population is a major driver of market growth in Japan. According to Europa, more than one in four people is over 65. As the geriatric population is at higher risk of various diseases and disabilities, an increase in the geriatric population may drive demand for wound care products.

Key Anti-biofilm Wound Dressing Company Insights

Competitive rivalry and market competition are expected to intensify over the forecast period due to the presence of major players. Companies are investing heavily in research and development to develop technologically advanced products and gain a competitive edge. For instance, in August 2025, Imbed Biosciences launched SAM PainGuard with Lidocaine, a dual-action antimicrobial wound matrix designed to manage bioburden and provide pain relief. The product leverages the company’s antimicrobial wound care technology platform and aligns with the industry's growing focus on advanced wound dressings that support infection control and improved wound-healing outcomes. Such product innovations are expected to drive growth in the anti-biofilm wound dressing market.

Companies are engaging in partnerships, mergers, and acquisitions to strengthen their product portfolios and manufacturing capacities and to achieve competitive differentiation. For instance, in May 2025, Mölnlycke Health Care completed the acquisition of P.G.F. Industry Solutions GmbH, the manufacturer of Granudacyn, a range of wound cleansing and moisturizing solutions. This initiative is expected to boost the company's growth.

Some prominent players in the global anti-biofilm wound dressing market include:

• In August 2025, Imbed Biosciences launched SAM PainGuard with Lidocaine, a dual-action antimicrobial wound matrix that combines bioburden management with pain relief. The product was developed for surgical, burn, and trauma wounds and underscores the growing focus on advanced antimicrobial wound care technologies to improve healing outcomes and infection control.

• In July 2025, Convatec received regulatory clearance in the U.S. and Europe for AQUACEL ConvaFiber, a next-generation Hydrofiber wound dressing designed for the management of diabetic foot ulcers, pressure injuries, surgical wounds, burns, and other chronic wounds. The development strengthens the company's advanced wound care portfolio and reflects ongoing innovation in wound dressing technologies.

Key Anti-Biofilm Wound Dressing Companies

The following key companies have been profiled for this study on the anti-biofilm wound dressing market

• ConvaTec Inc.

• Smith & Nephew PLC

• Urgo Medical

• Coloplast

• 3M

• Mölnlycke Health Care AB

• Imbed Biosciences

• Next Science

• B. Braun Melsungen AG

• Lohmann & Rauscher

Global Anti-biofilm Wound Dressing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global anti-biofilm wound dressing market report based on mode of mechanism, application, end use, and region:

To learn more about this report, Download Free Sample Report

• Mode of Mechanism Outlook (Revenue, USD Million, 2021 - 2033)

  • Physical

    • Manual Debridement

    • Pulse Electrical Field

    • Ultrasound Debridement

  • Chemical

    • Ionic Silver

    • Iodine

    • EDTA

    • Others

  • Biological

    • Dispersin B

    • Lactoferrin

    • Bacteriophage

    • Others

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Chronic Wounds

    • Diabetic Foot Ulcers

    • Pressure Ulcers

    • Venous Leg Ulcers

    • Others

  • Acute Wounds

    • Surgical & Traumatic Wounds

    • Burn Wounds

• End-use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals

  • Specialty Clinics

  • Home Healthcare

  • Others

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

    • Sweden

    • Denmark

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait